Results 181 to 190 of about 58,672 (263)

Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period

open access: green, 2022
Andrea M. Haqq   +11 more
openalex   +2 more sources

Melanocortin Peptides: Potential Targets in Systemic Lupus Erythematosus [PDF]

open access: yes, 2014
Erin Corey Connolly-Strong   +3 more
core   +1 more source

Human β-Defensin 1 and β-Defensin 3 (Mouse Ortholog mBD14) Function as Full Endogenous Agonists at Select Melanocortin Receptors

open access: green, 2018
Mark D. Ericson   +14 more
openalex   +1 more source

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

open access: green, 2004
Tricia J. Vos   +17 more
openalex   +1 more source

Home - About - Disclaimer - Privacy